NCT01248988 Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea Status COMPLETED Phase N/A
NCT01248975 Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma Status COMPLETED Phase PHASE2
NCT01248897 Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib Status COMPLETED Phase N/A
NCT01248884 Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) Status COMPLETED Phase PHASE2
NCT01248858 Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors. Status TERMINATED Phase PHASE1
NCT01248247 BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01246011 Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion Status TERMINATED Phase PHASE4
NCT01245426 A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1) Status COMPLETED Phase PHASE2
NCT01245062 GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma Status COMPLETED Phase PHASE3
NCT01245049 Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children Status COMPLETED Phase PHASE3
NCT01244984 A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma Status COMPLETED Phase PHASE3
NCT01243190 Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Status COMPLETED Phase PHASE2
NCT01239394 Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma Status COMPLETED Phase PHASE2
NCT01238029 Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer Status TERMINATED Phase PHASE1
NCT01236066 Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia Status COMPLETED Phase N/A
NCT01236040 Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old Status COMPLETED Phase PHASE1
NCT01235975 Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years Status COMPLETED Phase PHASE3